Life ScienceCompany
Portola Pharmaceuticals Ownership
Who owns Portola Pharmaceuticals?
Portola Pharmaceuticals is owned by Alexion Pharmaceuticals. It was acquired on May 5, 2020.
Was Portola Pharmaceuticals formerly PE-backed?
Yes. Portola Pharmaceuticals was formerly owned by 1 private investor.
Portola Pharmaceuticals Business Overview
Where is Portola Pharmaceuticals headquartered?
Portola Pharmaceuticals is headquartered in South San Francisco, California.
What is Portola Pharmaceuticals’ revenue?
Portola Pharmaceuticals disclosed revenue of 117M USD for 2019 and 40M USD for 2018.
How many employees does Portola Pharmaceuticals have?
Portola Pharmaceuticals has 324 employees.
What sector is Portola Pharmaceuticals in?
Portola Pharmaceuticals is a life science company.
When was Portola Pharmaceuticals founded?
Portola Pharmaceuticals was founded in 2003.
Life Science M&A Summary in 2020
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.
Join Mergr to view all 285 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 262 by strategics.